New compounds may address neuropathic pain in diabetes

06/28/2012 | MedicalDaily.com

Researchers at the University of California, Davis, found that a new class of compounds helped block a key enzyme called soluble epoxide hydrolase, inhibiting painful sensations in animal models. The results, published in the Proceedings of the National Academy of Sciences, may help address neuropathic pain associated with diabetes, researchers said.

View Full Article in:

MedicalDaily.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN